Why Hanmi Pharmaceutical is adding digital tools to its obesity drug
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
- Hanmi Pharmaceutical is combining its obesity drug Epe with a smartphone app for tracking weight, diet, exercise and side effects.
- Doctors can use the records to develop treatment strategies suited to individual patients.
Hanmi Pharmaceutical is combining its obesity drug Epe with digital health management as it treats obesity as a long-term battle rather than a short prescription course.
Patients prescribed the drug will be able to use a smartphone app to record weight loss, meals, exercise and how often side effects occur. Doctors can review those records and develop treatment strategies suited to each patient.
The company says it also plans to use the digital system to help patients improve their everyday habits.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.